We have located links that may give you full text access.
Triazine-based covalent organic frameworks for photodynamic inactivation of bacteria as type-II photosensitizers.
With the increase of antibiotic resistances in microorganisms, photodynamic inactivation (PDI) as a clinically proven antibacterial therapy is gaining increasing attention in recent years due to its high efficacy. Herein, we reported two covalent organic frameworks (COFs) materials, namely COFs-Trif-Benz and COF-SDU1, as effective type-II photosensitizers for photodynamic inactivation of bacteria. COFs-Trif-Benz and COF-SDU1 are synthesized through a facile solvothermal reaction between tri-(4-formacylphenoxy)-1,3,5-triazine (trif) and benzidine or p-phenylenediamine with high yield. Their highly ordered and porous structures were confirmed by Fourier transform infrared (FT-IR) spectra, solid state (13)C CP/MAS NMR spectrum, powder X-ray diffraction (PXRD) and Brunauer-Emmett-Teller (BET) analyses. The electronic absorption spectra and electrochemical experiments revealed that the extensive π-conjugation over COFs-Trif-Benz and COF-SDU1 greatly enhance their absorbance capability for visible light and make them have a lower band gap. The photocatalytic antibacterial assay was studied against both Gram-positive Staphylococcus aureus (S. aureus) and Gram-negative Escherichia coli O86:B7 (E. coli O86) bacteria. Two materials can kill more than 90% bacteria at concentrations of 100μgmL(-1) after 60-90min of illumination. Thus, both COFs are effective photosensitizers. Mechanism investigation revealed the antibacterial characteristics of the COFs-Trif-Benz and COF-SDU1 can generate reactive oxygen species (ROS) by energy transfer to molecular oxygen ((3)O2) to produce a highly reactive singlet oxygen ((1)O2). Hence, the two materials during the photodynamic were mainly via mechanism type II.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app